Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Fetal Tissue, Stem Cells & Bioethics

Stem Cell Awareness Day: Major Research Center’s Quest for Cures Uses Ethical Sources Only

Recently, numerous research facilities, both public and private, marked “Stem Cell Awareness Day,” holding lectures, issuing statements and highlighting ongoing progress in the field of regenerative medicine.

 

Among those participating was the University of California, Davis, one of the country’s leading institutions for stem cell research and regenerative medicine.  Writing in her local newspaper, the Davis Enterprise, Jan Nolta, the director of the Stem Cell Program at the UC Davis School of Medicine, highlighted the program’s “numerous novel clinical trials ongoing and in the pipeline” and its 16 disease teams testing stem cells to treat the following:

 

“peripheral vascular disease; heart disease; organ bioengineering and regeneration for liver, lung, bladder and kidney; blood disorders including leukemia; immune system disorders including HIV; restoration of hearing and sight; bone repair and cartilage regeneration; studying cancer stem cells to prevent relapse; skin repair including burns and non-healing ulcers; neurodevelopmental disorders including fragile X and autism spectrum-related disorders; and neurodegenerative diseases including Huntington’s disease, Alzheimer’s disease, Parkinson’s disease and ALS or Lou Gehrig’s disease.”

 

 

That is an impressive and ambitious list and success in treating even one or two of these diseases and conditions would benefit millions worldwide.

 

And from an ethical point of view, it is also impressive in that the clinical trials and disease teams at UC Davis are using ethically non-contentious adult and other non-embryonic sources of stem cells in their quest for cures.

 

The UC Davis Medical School’s website lists three clinical trials, for retinal occlusion, heart attack and peripheral vascular disease.  All three are utilizing adult stem cells, not embryonic stem cells.

 

Similarly, of the 12 disease teams featured on the website, all of them are using adult stem cells and other sources of non-embryonic stem cells to treat such diseases and conditions as Huntington’s, spina bifida, HIV and chronic diabetic wounds.

 

Over the years, UC Davis has been a major beneficiary of grants from the California Institute for Regenerative Medicine (CIRM).

 

As previously noted on this website, CIRM was founded just over a decade ago specifically to give funding priority to research using human embryonic stem cells (hESCR).  In its early grants, CIRM was true to this mission and the overwhelming number of grants and money awarded went to hESCR.

 

Yet as also detailed on this website, over the years more and more CIRM grants and money have gone to research programs using adult and other non-embryonic sources of stem cells (here and here), in particular, to research utilizing induced pluripotent stem cells (iPSCs).

 

The fact that such a major center for regenerative medicine as the UC Davis School of Medicine should rely so heavily on adult and other non-embryonic stem cells in its pursuit of cures is powerful testimony to the therapeutic promise and documented success of ethically non-contentious adult stem cell research and validates the long-standing contention that science need not kill to produce a cure.

 

Gene Tarne is Senior Analyst for the Charlotte Lozier Institute.

Latest Posts

July 11, 2024 Abortion Reporting: Alaska (2023) July 2, 2024 Experts: No Evidence Behind “Induced Abortion Is Evidence-Based Medical Care” Argument Experts: No Evidence Behind “Induced Abortion Is Evidence-Based Medical Care” Argument July 1, 2024 Is Induced Abortion Evidence-Based Medical Practice?

You Might Also Be Interested In

A Fact-Free Campaign Against Parents and Unborn Children in Alabama

April 22, 2024
Lozier Institute Amicus Brief in Support of Ecuador Law Limiting Abortion

Lozier Institute Amicus Brief in Support of Ecuador Law Limiting Abortion

charlotte-lozier-institute Charlotte Lozier Institute
February 21, 2024

Public Comment: Lozier Institute on CDC’s Notice of Proposed Modifications to Assisted Reproductive Technology Program Reporting

charlotte-lozier-institute Charlotte Lozier Institute
February 21, 2024

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image